White label – Pompe disease - ClinicalTrials.eu

Study of Narsoplimab for Children with High-Risk Blood Vessel Damage After Stem Cell Transplant

Recruiting

2 1 1
Investigated Diseases:
- Thrombotic microangiopathy
Investigated Drugs:
- Narsoplimab
Study of Amivantamab, Pembrolizumab, and Paclitaxel for Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Recruiting

1 1 1 1
Investigated Diseases:
- Squamous cell carcinoma of head and neck
Investigated Drugs:
Study on Modafinil for Improving Cognitive Deficits in Multiple Sclerosis Patients

Recruiting

2 1 1 1
Investigated Diseases:
- Multiple sclerosis
Investigated Drugs:
- Modafinil
Study on the Safety of Alprazolam for Treating Long Seizures in Patients Aged 12 and Older

Recruiting

3 1
Investigated Drugs:
- Alprazolam
+1
Study on Dexmedetomidine, Midazolam, and Lorazepam for Treating Acute Agitation in Emergency Psychiatry Patients

Recruiting

4 1 1 1
Investigated Diseases:
- Agitation
Investigated Drugs:
Study of ivosidenib in adults with advanced or metastatic chondrosarcoma with IDH1 mutation who are untreated or have had one prior treatment

Recruiting

3 1
Investigated Diseases:
- Chondrosarcoma
Investigated Drugs:
- Ivosidenib
+1
Study Comparing Trabectedin and Gemcitabine for Patients with Advanced or Metastatic Leiomyosarcoma After Chemotherapy

Recruiting

2 1 1 1
Investigated Diseases:
- Leiomyosarcoma
- Leiomyosarcoma metastatic
Investigated Drugs:
- Trabectedin
- Gemcitabine
Study of cefuroxime and metronidazole to prevent infections after Whipple’s procedure in patients with high risk of bile contamination

Recruiting

3 1 1 1
Investigated Drugs:
- Metronidazole
- Cefuroxime
Comparison of belantamab mafodotin, bortezomib and dexamethasone versus daratumumab, bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma

Recruiting

3 1 1 1
Investigated Drugs:
+3
Study to Determine the Best Dose of Zongertinib with Trastuzumab Deruxtecan or Trastuzumab Emtansine for Patients with Advanced HER2+ Metastatic Cancer

Recruiting

1 1 1 1
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies